로고
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
Search
Search
Company
People
History
Collaboration
Location
Science
Pipeline
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Animals
Growing Industry
Farm Animal
Companion Animal
IR
News
Events
Financial Information
FAQS
Jobs
Jobs
CLOSE

Companion Animal 



Dog Cancer Immunotherapy (PLS-D5000)

PLS-D5000 is a cancer Immune-therapy that directly attacks cancer cells and suppresses their reproduction. This product uses the same plasmid platform technology as PLS-D1000, however, it contains dTERT plasmids (Dog Telomerase Reverse Transcriptase) to target specifically the protein responsible for cancer cells replication.

This drug increases CD4 and CD8 T-cells, IFN-γ, (Interferon Gamma) CD107a (Cluster of Differentiation 107) and TNF-α (Tumor Necrosis Factor Alpha), and directly inhibits dTERT activity.
Experiments on infected rats and monkeys have confirmed a strong cytotoxic response, a delay of tumor growth and the rise in survival rate. We are expecting superior effects in dogs during further clinical trials.




Treatment for anemia caused by renal failure (PLS-D1000)

PLS-D1000 is a product that addresses anemia symptoms caused by renal failure in dogs and cats. This product alleviates anemia symptoms by increasing red blood cells, hematocrit and hemoglobin.

Some of potisive effets of PLS-D1000 are as follows, the results are as follows:



  • Average blood count of red blood cells, hemoglobin and hematocrit increased by about 7%
  • Increased IGF-I by about 25%
  • TNF-α (Tumor Necrosis Factor Alpha) reduced by a 40%
  • Increased circulating lymphocyte count by about 76%
  • Improved average weight by 11%
  • Extended lifetime in about 84% of the subjects.
  • Considerable life quality improvement.




How to Contact

You can share your opinion or inquire about our product pipeline